ANIXA BIOSCIENCES, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ANIXA BIOSCIENCES, INC. (ANIX) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $637.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-07-31 was $637.00K, a 23.16% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-04-30 was $637.00K, a 33.78% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-01-31 was $768.00K, a 25.51% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-10-31 was $859.00K, a 12.35% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $3.68M, a 16.72% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $4.42M, a 0.05% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $4.42M, a 26.30% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $6.00M, a 20.03% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $637.00K 10-Q · filed 2026-09-09 | $1.27M derived: sum of 2 quarters · filed 2026-09-09 | $2.04M 10-Q · filed 2026-09-09 | $2.90M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | $637.00K 10-Q · filed 2026-06-10 | $1.41M 10-Q · filed 2026-06-10 | $2.26M derived: sum of 3 quarters · filed 2026-06-10 | $3.09M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | $768.00K 10-Q · filed 2026-03-09 | $1.63M derived: sum of 2 quarters · filed 2026-03-09 | $2.46M derived: sum of 3 quarters · filed 2026-09-09 | $3.42M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $1.69M derived: sum of 2 quarters · filed 2026-09-09 | $2.65M derived: sum of 3 quarters · filed 2026-09-09 | $3.68M 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | $829.00K 10-Q · filed 2026-09-09 | $1.79M derived: sum of 2 quarters · filed 2026-09-09 | $2.82M 10-Q · filed 2026-09-09 | $3.80M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | $962.00K 10-Q · filed 2026-06-10 | $1.99M 10-Q · filed 2026-06-10 | $2.97M derived: sum of 3 quarters · filed 2026-06-10 | $4.07M derived: sum of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | $1.03M 10-Q · filed 2026-03-09 | $2.01M derived: sum of 2 quarters · filed 2026-03-09 | $3.10M derived: sum of 3 quarters · filed 2026-03-09 | $4.34M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | $980.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $2.07M derived: sum of 2 quarters · filed 2026-01-12 | $3.31M derived: sum of 3 quarters · filed 2026-01-12 | $4.42M 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | $1.09M 10-Q · filed 2025-09-10 | $2.33M derived: sum of 2 quarters · filed 2025-09-10 | $3.44M 10-Q · filed 2025-09-10 | $4.60M derived: sum of 4 quarters · filed 2025-09-10 | ||||
| 2024-04-30 | $1.24M 10-Q · filed 2025-05-28 | $2.35M 10-Q · filed 2025-05-28 | $3.50M derived: sum of 3 quarters · filed 2025-05-28 | $4.66M derived: sum of 4 quarters · filed 2025-05-28 | ||||
| 2024-01-31 | $1.11M 10-Q · filed 2025-03-11 | $2.27M derived: sum of 2 quarters · filed 2025-03-11 | $3.42M derived: sum of 3 quarters · filed 2025-03-11 | $4.57M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-10-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $2.31M derived: sum of 2 quarters · filed 2025-01-10 | $3.46M derived: sum of 3 quarters · filed 2025-01-10 | $4.42M 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | $1.15M 10-Q · filed 2024-09-06 | $2.31M derived: sum of 2 quarters · filed 2024-09-06 | $3.27M 10-Q · filed 2024-09-06 | $4.34M derived: sum of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | $1.16M 10-Q · filed 2024-06-04 | $2.11M 10-Q · filed 2024-06-04 | $3.18M derived: sum of 3 quarters · filed 2024-06-04 | $4.51M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | $957.00K 10-Q · filed 2024-03-12 | $2.03M derived: sum of 2 quarters · filed 2024-03-12 | $3.36M derived: sum of 3 quarters · filed 2024-03-12 | $4.82M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $2.40M derived: sum of 2 quarters · filed 2024-01-16 | $3.86M derived: sum of 3 quarters · filed 2024-01-16 | $6.00M 10-K · filed 2024-01-16 | ||||
| 2022-07-31 | $1.33M 10-Q · filed 2023-09-06 | $2.79M derived: sum of 2 quarters · filed 2023-09-06 | $4.93M 10-Q · filed 2023-09-06 | $7.63M derived: sum of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | $1.46M 10-Q · filed 2023-06-14 | $3.60M 10-Q · filed 2023-06-14 | $6.30M derived: sum of 3 quarters · filed 2023-06-14 | $9.34M derived: sum of 4 quarters · filed 2023-06-14 | ||||
| 2022-01-31 | $2.13M 10-Q · filed 2023-03-17 | $4.83M derived: sum of 2 quarters · filed 2023-03-17 | $7.88M derived: sum of 3 quarters · filed 2023-03-17 | $8.76M derived: sum of 4 quarters · filed 2023-03-17 | ||||
| 2021-10-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $5.75M derived: sum of 2 quarters · filed 2023-01-04 | $6.63M derived: sum of 3 quarters · filed 2023-01-04 | $7.50M 10-K · filed 2023-01-04 | $7.50M 10-K · filed 2022-01-04 | |||
| 2021-07-31 | $3.05M 10-Q · filed 2022-09-09 | $3.05M 10-Q · filed 2021-09-01 | $3.93M derived: sum of 2 quarters · filed 2022-09-09 | $4.80M 10-Q · filed 2022-09-09 | $4.80M 10-Q · filed 2021-09-01 | $5.71M derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | $881.00K 10-Q · filed 2022-06-10 | $880.78K 10-Q · filed 2021-06-10 | $1.76M 10-Q · filed 2022-06-10 | $1.76M 10-Q · filed 2021-06-10 | $2.66M derived: sum of 3 quarters · filed 2022-06-10 | $3.66M derived: sum of 4 quarters · filed 2022-06-10 | ||
| 2021-01-31 | $875.00K 10-Q · filed 2022-03-11 | $874.86K 10-Q · filed 2021-03-11 | $1.78M derived: sum of 2 quarters · filed 2022-03-11 | $2.78M derived: sum of 3 quarters · filed 2022-03-11 | $3.83M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | $906.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $1.90M derived: sum of 2 quarters · filed 2022-01-04 | $2.96M derived: sum of 3 quarters · filed 2022-01-04 | $3.92M 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | $997.09K 10-Q · filed 2021-09-01 | $2.05M derived: sum of 2 quarters · filed 2021-09-01 | $3.02M 10-Q · filed 2021-09-01 | $3.77M derived: sum of 4 quarters · filed 2021-09-01 | ||||
| 2020-04-30 | $1.06M 10-Q · filed 2021-06-10 | $2.02M 10-Q · filed 2021-06-10 | $2.77M derived: sum of 3 quarters · filed 2021-06-10 | $3.56M derived: sum of 4 quarters · filed 2021-06-10 | ||||
| 2020-01-31 | $963.88K 10-Q · filed 2021-03-11 | $1.72M derived: sum of 2 quarters · filed 2021-03-11 | $2.50M derived: sum of 3 quarters · filed 2021-03-11 | $3.31M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-10-31 | $751.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $1.54M derived: sum of 2 quarters · filed 2021-01-07 | $2.34M derived: sum of 3 quarters · filed 2021-01-07 | $3.56M 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | $784.25K 10-Q · filed 2020-09-08 | $1.59M derived: sum of 2 quarters · filed 2020-09-08 | $2.81M 10-Q · filed 2020-09-08 | $4.93M derived: sum of 4 quarters · filed 2020-09-08 | ||||
| 2019-04-30 | $805.10K 10-Q · filed 2020-06-09 | $2.02M 10-Q · filed 2020-06-09 | $4.14M derived: sum of 3 quarters · filed 2020-06-09 | $7.27M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-01-31 | $1.22M 10-Q · filed 2020-03-09 | $3.34M derived: sum of 2 quarters · filed 2020-03-09 | $6.46M derived: sum of 3 quarters · filed 2020-03-09 | $6.72M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $5.25M derived: sum of 2 quarters · filed 2020-01-09 | $5.50M derived: sum of 3 quarters · filed 2020-01-09 | $5.72M 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $3.13M 10-Q · filed 2019-09-06 | $3.38M derived: sum of 2 quarters · filed 2019-09-06 | $3.60M 10-Q · filed 2019-09-06 | $3.89M derived: sum of 4 quarters · filed 2019-09-06 | ||||
| 2018-04-30 | $258.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $472.53K 10-Q · filed 2019-06-12 | $759.23K derived: sum of 3 quarters · filed 2019-06-12 | $1.24M derived: sum of 4 quarters · filed 2019-06-12 | ||||
| 2018-01-31 | $214.43K 10-Q · filed 2018-03-09 | $501.12K derived: sum of 2 quarters · filed 2019-01-11 | $982.24K derived: sum of 3 quarters · filed 2019-01-11 | $1.17M derived: sum of 4 quarters · filed 2019-01-11 | ||||
| 2017-10-31 | $286.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $767.81K derived: sum of 2 quarters · filed 2019-01-11 | $959.73K derived: sum of 3 quarters · filed 2019-01-11 | $1.22M 10-K · filed 2019-01-11 | $1.22M 10-K · filed 2018-01-09 | |||
| 2017-07-31 | $481.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $673.04K derived: sum of 2 quarters · filed 2017-09-08 | $932.77K 10-Q · filed 2017-09-08 | $1.24M derived: sum of 4 quarters · filed 2018-01-09 | ||||
| 2017-04-30 | $191.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $451.65K 10-Q · filed 2017-05-26 | $755.03K derived: sum of 3 quarters · filed 2018-01-09 | $995.47K derived: sum of 4 quarters · filed 2018-01-09 | ||||
| 2017-01-31 | $259.74K 10-Q · filed 2017-03-16 | $563.11K derived: sum of 2 quarters · filed 2018-01-09 | $803.55K derived: sum of 3 quarters · filed 2018-01-09 | $1.02M derived: sum of 4 quarters · filed 2018-01-09 | ||||
| 2016-10-31 | $303.37K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $543.81K derived: sum of 2 quarters · filed 2018-01-09 | $761.07K derived: sum of 3 quarters · filed 2018-01-09 | $873.56K 10-K · filed 2018-01-09 | ||||
| 2016-07-31 | $240.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | $457.69K derived: sum of 2 quarters · filed 2016-08-19 | $570.19K 10-Q · filed 2016-08-19 | $908.20K derived: sum of 4 quarters · filed 2016-12-08 | ||||
| 2016-04-30 | $217.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $329.75K 10-Q · filed 2016-05-20 | $667.76K derived: sum of 3 quarters · filed 2016-12-08 | $1.45M derived: sum of 4 quarters · filed 2016-12-08 | ||||
| 2016-01-31 | $112.50K 10-Q · filed 2016-02-19 | $450.50K derived: sum of 2 quarters · filed 2016-12-08 | $1.23M derived: sum of 3 quarters · filed 2016-12-08 | $2.30M derived: sum of 4 quarters · filed 2016-12-08 | ||||
| 2015-10-31 | $338.01K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $1.12M derived: sum of 2 quarters · filed 2016-12-08 | $2.18M derived: sum of 3 quarters · filed 2016-12-08 | $2.68M 10-K · filed 2016-12-08 | ||||
| 2015-07-31 | $780.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $1.85M derived: sum of 2 quarters · filed 2015-08-18 | $2.34M 10-Q · filed 2015-08-18 | |||||
| 2015-04-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $1.56M 10-Q · filed 2015-05-22 | ||||||
| 2015-01-31 | $491.78K 10-Q · filed 2015-03-09 | |||||||
| 2014-10-31 | $3.15M 10-K · filed 2015-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |